Advertisement
Eli Lilly’s weight-loss pill seen generating billions, challenging Novo Nordisk
Business

Eli Lilly’s weight-loss pill seen generating billions, challenging Novo Nordisk

April 2, 2026
The Hindu BusinessLine
Scroll

Analysts forecast 2026 revenues between 1.5 billion and 2.8 billion, with long-term potential exceeding 40 billion

Eli Lilly’s weight-loss pill seen generating billions, challenging Novo Nordisk
Read Full Article
The Hindu BusinessLine
The Hindu BusinessLine

Coverage and analysis from India. All insights are generated by our AI narrative analysis engine.

India
Bias: lean right
Advertisement
You might also like

Explore More